← 返回

预测 CAR-T 细胞工程所需淋巴细胞采集的简便方法

英文原题:Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering.

查看英文原题

Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering.

PubMed 2025/01/13(内容时间) Transfus Clin Biol Q4 · IF 1.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

T 细胞采集的简易预测是一项重要工具,可帮助单采和血液学团队监测采集过程,无论涉及哪家公司及何种 CAR-T 细胞技术。

研究思路结论见上方概要

T 淋巴细胞采集对于难治性血液恶性肿瘤的 CAR-T 细胞工程至关重要,但需要优化。目前尚未建立预测所需采集 T 淋巴细胞数量的指南。采集的淋巴细胞数量,尤其是 T 细胞数量,取决于采集前淋巴细胞血液水平(pcLBL)和处理的血容量(BVs)数量。我们的目的是定义并标准化一种简单方法,用于预测采集的 T 淋巴细胞数量,同时考虑处理的血容量数量和 pcLBL,而不论不同公司定义的流程如何。

我们使用来自我们大型回顾性系列的数据,该系列包括407次采集会话,使用相同的细胞分离方法,涉及400名主要因非霍奇金淋巴瘤(NHL)或多发性骨髓瘤(MM)而随访的患者。我们最初使用采集效率(CE1和CE2)分析了淋巴细胞采集的性能,这些指数决定了尽可能采集更多细胞的能力,并评估了采集的中性粒细胞百分比。最后,我们评估了是否可以通过将pcLBL和BV数量乘以一个平均因子来轻松预测采集的T细胞数量。

在我们的系列中,总淋巴细胞和T细胞的CE1和CE2介于76 15%至69 15%之间,从而证实了细胞采集充分。采集到的中性粒细胞百分比较低(9 12%)。细胞采集充分的确认使我们考虑pcLBL与T细胞采集之间的关系。我们随后证明,采集到的T细胞数量与pcLBL相关,并且可以通过将每处理一个BV的pcLBL乘以2.5来预测。

展开英文摘要原文

We used data from our large retrospective series, which included 407 collection sessions using the same cytapheresis method in 400 patients mainly being followed up for non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM). We initially analysed the performance of lymphocyte collections using collection efficiencies (CE1 and CE2), which are indices that determine the ability to collect as many cells as possible, and also assessed the percentage of neutrophils collected. Finally, we evaluated whether the number of T cells collected could be easily predicted by multiplying the pcLBL and number of BVs by an average factor.

In our series, CE1 and CE2 for total lymphocytes and T cells were between 76 15% and 69 15%, thus confirming adequate cell collection. A low percentage of neutrophils was collected (9 12%). Confirmation of adequate cell collection led us to consider the relationship between pcLBL and T-cell collection. We then demonstrated that the amount of T cells collected correlated with pcLBL, and could be predicted by multiplying pcLBL by 2.5 for each BV processed.

Easy prediction of T-cell collection is an important tool that can help apheresis and haematology teams monitor collection sessions, regardless of the companies involved and CAR T-cell technology.

论文信息

作者
Hequet O、Mialou V、Cognasse F、Mazet S、Chelghoum Y、Revesz D、Candido C、Nicolas JF
单位
Apheresis Unit, EFS (Etablissement Français du Sang) Auvergne-Rhône-Alpes, Centre Hospitalier Lyon Sud (South Lyon Hospital), HCL (Hospices Civils de Lyon), Pierre Bénite, France; CIRI, International Centre for Infectiology Research, University of Lyon, INSERM, U1111, France. Electronic address: olivier.hequet@efs.sante.fr.France
期刊
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine2025 May
原文标识
PubMed 39814258 · DOI 10.1016/j.tracli.2025.01.005